AEMPS is recalling several batches of eye drops for conjunctivitis due to a quality defect.

New health warning. Spanish Agency for Medicines and Health Products discovered defects in the preparation common in Spain. In particular, this is a cure for conjunctivitis: eye drops. The agency ordered his withdrawal on 30 August.

It’s about Ketobrilla, Brill Pharma eye drops. There are several affected parties that do not comply with the provisions. Exact reason for withdrawal: “reuse of sterile filters during its production without confirmation of such reuse.

There are several lots that they expire in 2023 and 2024.. This is why all distributed units of the affected parties must leave the market and return to the lab. Recently, AEMPS He also ordered that other medicines be discontinued.

What packages are affected?

Eat three lots affected They need to be taken off the market immediately. These are the following:

  • Lot: 21J004, expiration date 08/31/2023.
  • Batch: 22C049, expiration date 02/28/2024..
  • Lot: 22D022, expiration date 03/31/2024.

AEMPS has indicated that this warning is a “quality defect which not life-threatening for the patient”, but advises against using them.

Source link

Leave a Comment